Statistical methodology for screening studies with qualitative/quantitative mixtures

DOI10.1080/10543409808835223zbMATH Open0952.62096OpenAlexW2093268147WikidataQ40862990 ScholiaQ40862990MaRDI QIDQ4512658FDOQ4512658

Authors: Ralph A. Demasi, Dana Quade, Chuan-Feng Shih 

Publication date: 21 January 2001

Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/10543409808835223

Recommendations

• Bayesian Optimal Design for Phase II Screening Trials
• A prospective combination of phase II and phase III in drug development
• Screening
• scientific article; zbMATH DE number 3984436
• Screening designs for drug development

zbMATH Keywords

powerranking and selectionphase II clinical trialoperating characteristic contour plotsqualitative and quantitative observations

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Title not available (Why is that?)
• Title not available (Why is that?)
• Sample Size Determination for Some Common Nonparametric Tests
• Dissolution test acceptance sampling plans

Uses Software

• SAS

This page was built for publication: Statistical methodology for screening studies with qualitative/quantitative mixtures

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4512658)